About three months into the ongoing monkeypox outbreak in the US, there are more than 12,000 cases and counting.
But despite a growing supply of the Jynneos vaccine — and a new strategy that could stretch the current supply five times further — there is still no evidence that protection is reaching those most at risk.
“If you think about the reality that there’s a limited amount of vaccinations available, you really want to understand which groups to go after first,” said Dr. Stella Safo, an HIV primary care physician and founder of the advocacy group Just Equity for Health.
“That is the equity lens — that we’re not all experiencing diseases and different social determinants of health equally. So therefore, the treatments and the available resources should also target those who need them the most.”